339 related articles for article (PubMed ID: 24356887)
1. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
Huang XZ; Wen D; Zhang M; Xie Q; Ma L; Guan Y; Ren Y; Chen J; Hao CM
J Cell Biochem; 2014 May; 115(5):996-1005. PubMed ID: 24356887
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3.
Li J; Qu X; Ricardo SD; Bertram JF; Nikolic-Paterson DJ
Am J Pathol; 2010 Sep; 177(3):1065-71. PubMed ID: 20651248
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 1 Activation Reduces Transforming Growth Factor-β1-Induced Fibrogenesis and Affords Organ Protection in a Model of Progressive, Experimental Kidney and Associated Cardiac Disease.
Zhang Y; Connelly KA; Thai K; Wu X; Kapus A; Kepecs D; Gilbert RE
Am J Pathol; 2017 Jan; 187(1):80-90. PubMed ID: 27993241
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 activation ameliorates rhesus monkey liver fibrosis by inhibiting the TGF-β/smad signaling pathway.
Xia Y; Luo Q; Gao Q; Huang C; Chen P; Zou Y; Chen X; Liu W; Chen Z
Chem Biol Interact; 2024 May; 394():110979. PubMed ID: 38555046
[TBL] [Abstract][Full Text] [Related]
5. Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling.
Chen Y; He T; Zhang Z; Zhang J
Pharmacology; 2021; 106(11-12):667-681. PubMed ID: 34518478
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
[TBL] [Abstract][Full Text] [Related]
7. Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.
Wang M; Chen DQ; Chen L; Liu D; Zhao H; Zhang ZH; Vaziri ND; Guo Y; Zhao YY; Cao G
J Agric Food Chem; 2018 Feb; 66(8):1828-1842. PubMed ID: 29383936
[TBL] [Abstract][Full Text] [Related]
8. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
9. CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.
Ren Y; Du C; Yan L; Wei J; Wu H; Shi Y; Duan H
Drug Des Devel Ther; 2015; 9():4155-71. PubMed ID: 26257513
[TBL] [Abstract][Full Text] [Related]
10. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol ameliorates muscle atrophy in chronic kidney disease via the axis of SIRT1/FoxO1.
Wang R; Yuan W; Li L; Lu F; Zhang L; Gong H; Huang X
Phytother Res; 2022 Aug; 36(8):3265-3275. PubMed ID: 35606908
[TBL] [Abstract][Full Text] [Related]
12. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
13. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H
Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797
[TBL] [Abstract][Full Text] [Related]
14. Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway.
Wang M; Yang L; Yang J; Wang C
BMC Complement Altern Med; 2019 May; 19(1):107. PubMed ID: 31118021
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway.
Zhang W; Rong G; Gu J; Fan C; Guo T; Jiang T; Deng W; Xie J; Su Z; Yu Q; Mai J; Zheng R; Chen X; Tang X; Zhang J
FASEB J; 2022 Mar; 36(3):e22084. PubMed ID: 35107844
[TBL] [Abstract][Full Text] [Related]
16. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
[TBL] [Abstract][Full Text] [Related]
17. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
18. Expression of miR-207 in renal tissue of renal fibrosis rats and its correlation analysis with protein expression of TGF-β1 and Smad3.
Tian F; Zhang ZY; Sun J; Han YC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):787-794. PubMed ID: 33577033
[TBL] [Abstract][Full Text] [Related]
19. Redox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity.
Overstreet JM; Samarakoon R; Meldrum KK; Higgins PJ
Cell Signal; 2014 Jul; 26(7):1427-36. PubMed ID: 24613410
[TBL] [Abstract][Full Text] [Related]
20. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
